首页 > 最新文献

Clinical Medicine Insights-Endocrinology and Diabetes最新文献

英文 中文
Diabetes-Associated Osteoporosis: A Case of Vertebral Compression Fracture in a Middle-Aged Man with Poor Glycemic Control. 糖尿病相关性骨质疏松:1例血糖控制不良的中年男性椎体压缩性骨折。
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-29 eCollection Date: 2025-01-01 DOI: 10.1177/11795514251326838
Saleh Shalalfa, Neveen Shalalfa, Mays Najjar, Zeina Sheeb, Ahmad Barakat

Diabetes mellitus is associated with an increased risk of osteoporosis and fractures due to impaired bone metabolism and increased fall risk. This case report highlights a 49-year-old Palestinian man with long-standing poorly controlled type 2 diabetes who presented with progressive back pain following a hypoglycemic syncopal episode. Clinical assessment and imaging, including magnetic resonance imaging (MRI) and Dual-Energy X-ray Absorptiometry (DEXA), confirmed a vertebral compression fracture at D12-L1 and severe osteoporosis. Laboratory investigations ruled out secondary causes of osteoporosis. The patient was treated with zoledronic acid, pain management, and improved glycemic control, leading to symptom relief and better metabolic outcomes after 6 months. This case underscores the importance of early osteoporosis screening in diabetic patients and highlights the need for an integrated approach to managing both diabetes and bone health to prevent fractures in high-risk individuals.

由于骨代谢受损和跌倒风险增加,糖尿病与骨质疏松和骨折风险增加有关。本病例报告强调了一名49岁的巴勒斯坦男性长期控制不良的2型糖尿病,他在低血糖晕厥发作后出现进行性背部疼痛。临床评估和影像学检查,包括磁共振成像(MRI)和双能x线骨密度仪(DEXA),证实D12-L1椎体压缩性骨折和严重骨质疏松症。实验室调查排除了骨质疏松的继发性原因。患者接受唑来膦酸治疗、疼痛管理和血糖控制改善,6个月后症状缓解,代谢结果改善。本病例强调了糖尿病患者早期骨质疏松筛查的重要性,并强调了需要综合方法来管理糖尿病和骨骼健康,以防止高危人群骨折。
{"title":"Diabetes-Associated Osteoporosis: A Case of Vertebral Compression Fracture in a Middle-Aged Man with Poor Glycemic Control.","authors":"Saleh Shalalfa, Neveen Shalalfa, Mays Najjar, Zeina Sheeb, Ahmad Barakat","doi":"10.1177/11795514251326838","DOIUrl":"10.1177/11795514251326838","url":null,"abstract":"<p><p>Diabetes mellitus is associated with an increased risk of osteoporosis and fractures due to impaired bone metabolism and increased fall risk. This case report highlights a 49-year-old Palestinian man with long-standing poorly controlled type 2 diabetes who presented with progressive back pain following a hypoglycemic syncopal episode. Clinical assessment and imaging, including magnetic resonance imaging (MRI) and Dual-Energy X-ray Absorptiometry (DEXA), confirmed a vertebral compression fracture at D12-L1 and severe osteoporosis. Laboratory investigations ruled out secondary causes of osteoporosis. The patient was treated with zoledronic acid, pain management, and improved glycemic control, leading to symptom relief and better metabolic outcomes after 6 months. This case underscores the importance of early osteoporosis screening in diabetic patients and highlights the need for an integrated approach to managing both diabetes and bone health to prevent fractures in high-risk individuals.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514251326838"},"PeriodicalIF":2.7,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting. 医院新诊断2型糖尿病患者的临床特点及处理
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-12 eCollection Date: 2025-01-01 DOI: 10.1177/11795514251323831
Diego Muñoz Moreno, Gilberto Pérez López, Luis Antonio Álvarez-Sala Walther, José Antonio Rueda Camino, Javier Martín Vallejo, Olga González Albarrán

Background: New-onset type 2 diabetes mellitus (T2DM) is a common clinical scenario in the hospital settings. However, data on the baseline characteristics of these patients at diagnosis in Spain remain limited.

Objectives: This study aims to describe the characteristics of 165 patients admitted to a Spanish tertiary hospital with new-onset T2DM. We analysed the use of different treatment regimens at discharge and metabolic control during follow-up.

Methods: A retrospective, single-centre cohort study was conducted at General University Gregorio Marañón Hospital, between January 2018 and April 2021.

Results: A total of 165 patients participated, with a mean age of 56.4 years, 62.4% of whom were men. Diabetes-related complications were observed in 24.8% of patients at diagnosis. Combined antidiabetic treatment was required in 87% of cases. The mean baseline HbA1c was 10.8%, which decreased by 4.9% after 8 months of follow-up.

Conclusion: The clinical heterogeneity and severity of hyperglycaemia in this cohort presented management challenges, in contrast to outpatient settings. Monotherapy was rarely used, with higher adoption of SGLT-2 inhibitors and GLP-1 receptor agonists compared to other studies. Additional research is needed to refine treatment strategies and optimize care for patients with newly diagnosed T2DM.

背景:新发2型糖尿病(T2DM)是医院常见的临床情况。然而,这些患者在西班牙诊断时的基线特征数据仍然有限。目的:本研究旨在描述西班牙三级医院收治的165例新发T2DM患者的特征。我们分析了出院时不同治疗方案的使用和随访期间的代谢控制。方法:2018年1月至2021年4月,在Gregorio综合大学Marañón医院进行了一项回顾性单中心队列研究。结果:共165例患者参与,平均年龄56.4岁,男性占62.4%。24.8%的患者在诊断时出现糖尿病相关并发症。87%的病例需要联合抗糖尿病治疗。平均基线HbA1c为10.8%,随访8个月后下降4.9%。结论:与门诊情况相比,该队列中高血糖的临床异质性和严重程度提出了管理挑战。很少使用单药治疗,与其他研究相比,SGLT-2抑制剂和GLP-1受体激动剂的使用率更高。需要进一步的研究来完善治疗策略和优化对新诊断T2DM患者的护理。
{"title":"Clinical Profile and Management of Patients with Newly Diagnosed Type 2 Diabetes Mellitus in Hospital Setting.","authors":"Diego Muñoz Moreno, Gilberto Pérez López, Luis Antonio Álvarez-Sala Walther, José Antonio Rueda Camino, Javier Martín Vallejo, Olga González Albarrán","doi":"10.1177/11795514251323831","DOIUrl":"10.1177/11795514251323831","url":null,"abstract":"<p><strong>Background: </strong>New-onset type 2 diabetes mellitus (T2DM) is a common clinical scenario in the hospital settings. However, data on the baseline characteristics of these patients at diagnosis in Spain remain limited.</p><p><strong>Objectives: </strong>This study aims to describe the characteristics of 165 patients admitted to a Spanish tertiary hospital with new-onset T2DM. We analysed the use of different treatment regimens at discharge and metabolic control during follow-up.</p><p><strong>Methods: </strong>A retrospective, single-centre cohort study was conducted at General University Gregorio Marañón Hospital, between January 2018 and April 2021.</p><p><strong>Results: </strong>A total of 165 patients participated, with a mean age of 56.4 years, 62.4% of whom were men. Diabetes-related complications were observed in 24.8% of patients at diagnosis. Combined antidiabetic treatment was required in 87% of cases. The mean baseline HbA1c was 10.8%, which decreased by 4.9% after 8 months of follow-up.</p><p><strong>Conclusion: </strong>The clinical heterogeneity and severity of hyperglycaemia in this cohort presented management challenges, in contrast to outpatient settings. Monotherapy was rarely used, with higher adoption of SGLT-2 inhibitors and GLP-1 receptor agonists compared to other studies. Additional research is needed to refine treatment strategies and optimize care for patients with newly diagnosed T2DM.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514251323831"},"PeriodicalIF":2.7,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11898092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic Ketoacidosis Caused by Acute Pancreatitis Results in Severe Hypertriglyceridemia: A Case Report. 急性胰腺炎引起的糖尿病酮症酸中毒导致严重高甘油三酯血症1例报告。
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-27 eCollection Date: 2025-01-01 DOI: 10.1177/11795514251323826
Amirpasha Mansour, Shima Ghasemzade

Diabetic ketoacidosis (DKA) is an acute complication of diabetes that mainly occurs in type 1 diabetes. However, it can also occur in type 2 diabetes, although less commonly. One of the rare causes of this condition is acute pancreatitis. While hypertriglyceridemia is a known complication of DKA, triglyceride levels higher than 2000 are an unusual finding. We present a case of undiagnosed type 2 diabetes mellitus in a patient who came to the hospital with epigastric pain, nausea, and vomiting. Subsequent blood tests revealed hyperglycemia, ketonuria, metabolic acidosis, and increased levels of amylase and lipase, leading to a simultaneous diagnosis of DKA, acute pancreatitis, and very severe hypertriglyceridemia. In patients experiencing abdominal pain and severe diabetic complications, acute pancreatitis should always be considered as a possible diagnosis, and triglyceride levels should be tested to identify hypertriglyceridemia as a potential cause of pancreatitis or complications of DKA.

糖尿病酮症酸中毒(DKA)是糖尿病的一种急性并发症,主要发生于1型糖尿病。然而,它也可能发生在2型糖尿病中,尽管不太常见。其中一个罕见的原因是急性胰腺炎。虽然高甘油三酯血症是已知的DKA并发症,但甘油三酯水平高于2000是不寻常的发现。我们报告一例未确诊的2型糖尿病患者,因上腹疼痛、恶心和呕吐来到医院。随后的血液检查显示高血糖、酮尿、代谢性酸中毒、淀粉酶和脂肪酶水平升高,导致DKA、急性胰腺炎和非常严重的高甘油三酯血症的同时诊断。对于出现腹痛和严重糖尿病并发症的患者,应始终将急性胰腺炎视为可能的诊断,并应检测甘油三酯水平,以确定高甘油三酯血症是否是胰腺炎或DKA并发症的潜在原因。
{"title":"Diabetic Ketoacidosis Caused by Acute Pancreatitis Results in Severe Hypertriglyceridemia: A Case Report.","authors":"Amirpasha Mansour, Shima Ghasemzade","doi":"10.1177/11795514251323826","DOIUrl":"10.1177/11795514251323826","url":null,"abstract":"<p><p>Diabetic ketoacidosis (DKA) is an acute complication of diabetes that mainly occurs in type 1 diabetes. However, it can also occur in type 2 diabetes, although less commonly. One of the rare causes of this condition is acute pancreatitis. While hypertriglyceridemia is a known complication of DKA, triglyceride levels higher than 2000 are an unusual finding. We present a case of undiagnosed type 2 diabetes mellitus in a patient who came to the hospital with epigastric pain, nausea, and vomiting. Subsequent blood tests revealed hyperglycemia, ketonuria, metabolic acidosis, and increased levels of amylase and lipase, leading to a simultaneous diagnosis of DKA, acute pancreatitis, and very severe hypertriglyceridemia. In patients experiencing abdominal pain and severe diabetic complications, acute pancreatitis should always be considered as a possible diagnosis, and triglyceride levels should be tested to identify hypertriglyceridemia as a potential cause of pancreatitis or complications of DKA.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514251323826"},"PeriodicalIF":2.7,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long Term Outcomes After Flexor Tendon Tenotomy of the Diabetic Foot. 糖尿病足屈肌腱肌腱切断术后的远期疗效。
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-24 eCollection Date: 2025-01-01 DOI: 10.1177/11795514251314787
Jonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, Klaus Kirketerp-Møller, Peter Rossing

Background: Hammertoes is one if not the most common deformity that afflicts the diabetic foot and leads to increased risk of diabetic foot ulcers. Flexor tendon tenotomy treatment of the diabetic hammertoe has gained increased interest and is now recommended in international guidelines as a treatment of hammertoes to prevent diabetic foot ulcers. There is however no published data on the long term outcomes following tenotomy treatment.

Introduction: The objectives of this study was to describe the demographics and long-term outcomes following tenotomy treatment of individuals with diabetes who had flexor tendon tenotomies of hammertoes performed between 2006 and 2009.

Methods: This was an observational study of a cohort from a prior study. The study was performed at Steno Diabetes Center Copenhagen between 1st of January 2020 and 31st of June 2020. Participants from the prior study were invited to join the study, consisting of one visit where foot examination was performed by orthopedic surgeon. Information on medical history was obtained from medical records.

Results: Of the original 38 operated participants, 21 (55.3%) had died during the follow-up period, one (2.6%) had moved away, and one (2.6%) had incorrect procedure performed originally. At follow-up (mean 149.7 months (±17)), age of the remaining 15 participants (86.7% male) was 66.6 years (±11.4), diabetes duration was 32.2 years (±13.3), all had neuropathy and 14 (93.3%) had palpable foot pulses. The 15 Included participants had 22 toes tenotomized in the original study, of which five toes (22.7%) in four participants (26.7%) had recurrent hammertoe deformities. Of the 15 participants, 14 (93.3%) had incurred at least one ulcer during the observation period, and eight (53.3%) had incurred an amputation.

Conclusion: This study reports an undescribed risk of recurrence of deformities after tenotomies and supports that this population is at high risk of new ulcers, amputations, and have a high mortality rate.

背景:锤状趾是糖尿病足最常见的畸形之一,导致糖尿病足溃疡的风险增加。糖尿病锤状趾的屈肌腱肌腱切断术治疗已引起越来越多的关注,现在在国际指南中推荐作为锤状趾的治疗方法来预防糖尿病足溃疡。然而,没有关于肌腱切开术治疗后长期结果的公开数据。简介:本研究的目的是描述2006年至2009年间进行锤状趾屈肌腱切断术的糖尿病患者的人口统计学和长期结果。方法:这是一项来自先前研究的队列观察性研究。该研究于2020年1月1日至2020年6月31日在哥本哈根Steno糖尿病中心进行。先前研究的参与者被邀请加入研究,包括一次由骨科医生进行足部检查的访问。病史资料来自医疗记录。结果:在最初的38例手术参与者中,21例(55.3%)在随访期间死亡,1例(2.6%)移走,1例(2.6%)最初执行的手术不正确。在随访(平均149.7个月(±17))时,其余15名参与者(86.7%为男性)的年龄为66.6岁(±11.4)岁,糖尿病病程为32.2年(±13.3)年,所有参与者均有神经病变,14名参与者(93.3%)有可触及的足部脉搏。纳入的15名参与者在最初的研究中有22个脚趾被切除,其中4名参与者(26.7%)的5个脚趾(22.7%)有复发性槌状趾畸形。在15名参与者中,14名(93.3%)在观察期间至少发生过一次溃疡,8名(53.3%)发生过截肢。结论:本研究报告了肌腱切断术后畸形复发的未描述风险,并支持这一人群发生新溃疡、截肢的风险高,死亡率高。
{"title":"Long Term Outcomes After Flexor Tendon Tenotomy of the Diabetic Foot.","authors":"Jonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, Klaus Kirketerp-Møller, Peter Rossing","doi":"10.1177/11795514251314787","DOIUrl":"10.1177/11795514251314787","url":null,"abstract":"<p><strong>Background: </strong>Hammertoes is one if not the most common deformity that afflicts the diabetic foot and leads to increased risk of diabetic foot ulcers. Flexor tendon tenotomy treatment of the diabetic hammertoe has gained increased interest and is now recommended in international guidelines as a treatment of hammertoes to prevent diabetic foot ulcers. There is however no published data on the long term outcomes following tenotomy treatment.</p><p><strong>Introduction: </strong>The objectives of this study was to describe the demographics and long-term outcomes following tenotomy treatment of individuals with diabetes who had flexor tendon tenotomies of hammertoes performed between 2006 and 2009.</p><p><strong>Methods: </strong>This was an observational study of a cohort from a prior study. The study was performed at Steno Diabetes Center Copenhagen between 1st of January 2020 and 31st of June 2020. Participants from the prior study were invited to join the study, consisting of one visit where foot examination was performed by orthopedic surgeon. Information on medical history was obtained from medical records.</p><p><strong>Results: </strong>Of the original 38 operated participants, 21 (55.3%) had died during the follow-up period, one (2.6%) had moved away, and one (2.6%) had incorrect procedure performed originally. At follow-up (mean 149.7 months (±17)), age of the remaining 15 participants (86.7% male) was 66.6 years (±11.4), diabetes duration was 32.2 years (±13.3), all had neuropathy and 14 (93.3%) had palpable foot pulses. The 15 Included participants had 22 toes tenotomized in the original study, of which five toes (22.7%) in four participants (26.7%) had recurrent hammertoe deformities. Of the 15 participants, 14 (93.3%) had incurred at least one ulcer during the observation period, and eight (53.3%) had incurred an amputation.</p><p><strong>Conclusion: </strong>This study reports an undescribed risk of recurrence of deformities after tenotomies and supports that this population is at high risk of new ulcers, amputations, and have a high mortality rate.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514251314787"},"PeriodicalIF":2.7,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11848885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143494082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Different Metabolic Indicators on Ventricular Repolarization Indices in Obese Children: A Case Control Study. 不同代谢指标对肥胖儿童心室复极指数的影响:一项病例对照研究
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-02-06 eCollection Date: 2025-01-01 DOI: 10.1177/11795514251316248
Asmaa A El Sehmawy, Rasha Abd El Samad Fawaz, Nadia Ahmed Agiba, Eman Aziz Elsherbiny, Nglaa Fathi Agaba, Doaa Sayed Mohammed, Haidy Mahmoud Nasr, Fatma Elzhraa Ae Diab, Amal M Ahmed, Shorouk Issa Mahfouz, Heba T Okda, Doaa Sadek Ahmed

Background: Obesity, insulin resistance, and dyslipidemia may impact ventricular repolarization in children.

Objectives: The study aimed to identify the relationship between various metabolic indicators and ventricular repolarization indices among obese children compared to healthy ones.

Methods: A case-control study included 90 children, divided into two groups: 45 obese children (cases) and 45 children with normal weight (controls). Electrocardiogram (ECG) readings were analyzed to calculate several parameters, including corrected QT (QTc), QTc dispersion (QTcd), JTc dispersion, and the TpTe interval, using 12-lead surface ECGs. Both groups were also assessed for lipid profiles, fasting plasma glucose (FPG), and serum insulin to calculate the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR).

Results: Obese children had significantly higher serum levels of triglycerides, cholesterol, LDL, fasting insulin, and HOMA-IR compared to controls. Also, they significantly had longer mean values of QTcd and JTcd with no significant difference in TpTe interval between both groups. A significant positive correlation was detected between QTc and JTc dispersion and the following variables: waist circumference, body mass index (BMI), blood pressure, fasting insulin, HOMA-IR index, and LDL. Additionally, no significant difference was revealed between obese children with and without metabolic syndrome regarding ventricular repolarization ECG parameters.

Conclusion: Greater JTc dispersion (ms) and QTc dispersion (ms) were observed in obese children with a positive correlation to waist circumference, BMI, and insulin resistance.

背景:肥胖、胰岛素抵抗和血脂异常可能影响儿童心室复极。目的:探讨肥胖儿童与健康儿童不同代谢指标和心室复极指数之间的关系。方法:采用病例-对照研究方法,将90例儿童分为肥胖儿童(病例)45例和正常体重儿童(对照组)45例。分析心电图(ECG)读数,计算几个参数,包括校正QT (QTc)、QTc离散度(QTcd)、JTc离散度和TpTe间期,使用12导联表面心电图。两组还评估血脂、空腹血糖(FPG)和血清胰岛素,以计算胰岛素抵抗的稳态模型评估(HOMA-IR)。结果:与对照组相比,肥胖儿童的血清甘油三酯、胆固醇、低密度脂蛋白、空腹胰岛素和HOMA-IR水平显著升高。QTcd和JTcd的平均值也明显延长,两组间TpTe间隔无显著差异。QTc和JTc离散度与腰围、体重指数(BMI)、血压、空腹胰岛素、HOMA-IR指数、LDL呈显著正相关。此外,伴有和不伴有代谢综合征的肥胖儿童心室复极心电图参数无显著差异。结论:肥胖儿童JTc弥散度(ms)、QTc弥散度(ms)增大,与腰围、BMI、胰岛素抵抗呈正相关。
{"title":"Impact of Different Metabolic Indicators on Ventricular Repolarization Indices in Obese Children: A Case Control Study.","authors":"Asmaa A El Sehmawy, Rasha Abd El Samad Fawaz, Nadia Ahmed Agiba, Eman Aziz Elsherbiny, Nglaa Fathi Agaba, Doaa Sayed Mohammed, Haidy Mahmoud Nasr, Fatma Elzhraa Ae Diab, Amal M Ahmed, Shorouk Issa Mahfouz, Heba T Okda, Doaa Sadek Ahmed","doi":"10.1177/11795514251316248","DOIUrl":"10.1177/11795514251316248","url":null,"abstract":"<p><strong>Background: </strong>Obesity, insulin resistance, and dyslipidemia may impact ventricular repolarization in children.</p><p><strong>Objectives: </strong>The study aimed to identify the relationship between various metabolic indicators and ventricular repolarization indices among obese children compared to healthy ones.</p><p><strong>Methods: </strong>A case-control study included 90 children, divided into two groups: 45 obese children (cases) and 45 children with normal weight (controls). Electrocardiogram (ECG) readings were analyzed to calculate several parameters, including corrected QT (QTc), QTc dispersion (QTcd), JTc dispersion, and the TpTe interval, using 12-lead surface ECGs. Both groups were also assessed for lipid profiles, fasting plasma glucose (FPG), and serum insulin to calculate the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR).</p><p><strong>Results: </strong>Obese children had significantly higher serum levels of triglycerides, cholesterol, LDL, fasting insulin, and HOMA-IR compared to controls. Also, they significantly had longer mean values of QTcd and JTcd with no significant difference in TpTe interval between both groups. A significant positive correlation was detected between QTc and JTc dispersion and the following variables: waist circumference, body mass index (BMI), blood pressure, fasting insulin, HOMA-IR index, and LDL. Additionally, no significant difference was revealed between obese children with and without metabolic syndrome regarding ventricular repolarization ECG parameters.</p><p><strong>Conclusion: </strong>Greater JTc dispersion (ms) and QTc dispersion (ms) were observed in obese children with a positive correlation to waist circumference, BMI, and insulin resistance.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514251316248"},"PeriodicalIF":2.7,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11803729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between LRP-5 and LRP-6 Gene Mutations and Postmenopausal Type 2 Diabetes and Obesity. LRP-5和LRP-6基因突变与绝经后2型糖尿病和肥胖的关系
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-26 eCollection Date: 2025-01-01 DOI: 10.1177/11795514241307180
Jun Li, Ya Li, Yunqiu Lu, Siyuan Li, Yecheng Zhu, Chuanbing Sun, Partab Rai, Xuehai Jia

Background: Single nucleotide polymorphisms (SNPs) in the low-density lipoprotein receptor-related protein 5 (LRP5) and the low-density lipoprotein receptor-related protein 5 (LRP6) genes have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and obesity (OB). This study aimed to evaluate the polymorphisms in LRP5 and LRP6 genes in postmenopausal patients with T2DM and OB.

Methods: Participants were categorized into the Non-T2DM group (n = 53) and the T2DM group (n = 89) based on glycemic levels. Baseline data and biochemical indices were collected, Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry, and SNPs at the LRP5 and LRP6 loci were assessed by time-of-flight mass spectrometry.

Results: 1. There was a statistical difference in the distribution of genotypes (CC/CT) at locus rs4988331 (χ2 = 67.940, P = .000) and in the distribution of alleles (C/T) between the T2DM and non-T2DM groups (χ2 = 50.506, P = .000). Additionally, there were significant differences in the allele (G/A) at locus rs11054704, and both allele (G/T) and genotype (GG/GT) distributions at locus rs1181334 between the OB group and the normal weight group (P < .05). 2. OB was identified as a risk factor for T2DM in individuals with the wild-type at locus rs1181334, and the interaction between wild-type and mutant was significant (P < .05). 3. Multifactorial logistic regression analysis revealed that BMD (OR 3.755; 95% CI, 1.215-11.608) and triglyceride-glucose (TyG) index (OR 2.855; 95% CI, 1.361-5.986) were risk factors for T2DM in postmenopausal women, whereas alkaline phosphatase (ALP; OR 0.970; 95% CI, 0.945-0.995) and rs4988331 mutation (OR 0.018; 95% CI, 0.006-0.060) were protective factors.

Conclusion: Mutations at the LRP5-rs4988331 locus, as well as the LRP6-rs11054704 and rs1181334 loci, may be associated with the development of T2DM and OB in postmenopausal women.

背景:低密度脂蛋白受体相关蛋白5 (LRP5)和低密度脂蛋白受体相关蛋白5 (LRP6)基因的单核苷酸多态性(snp)与2型糖尿病(T2DM)和肥胖(OB)的发病机制有关。本研究旨在评估绝经后T2DM和ob患者中LRP5和LRP6基因的多态性。方法:根据血糖水平将参与者分为非T2DM组(n = 53)和T2DM组(n = 89)。收集基线数据和生化指标,采用双能x线吸收仪测量骨密度(BMD),采用飞行时间质谱法评估LRP5和LRP6位点的snp。结果:1。T2DM组与非T2DM组rs4988331位点基因型(CC/CT)分布差异有统计学意义(χ2 = 67.940, P = 0.000),等位基因(C/T)分布差异有统计学意义(χ2 = 50.506, P = 0.000)。此外,在rs11054704位点的等位基因(G/A)、rs1181334位点的等位基因(G/T)和基因型(GG/GT)分布在OB组和正常体重组之间存在显著差异(P P)。结论:LRP5-rs4988331位点突变、LRP6-rs11054704和rs1181334位点突变可能与绝经后妇女T2DM和OB的发生有关。
{"title":"The Relationship Between LRP-5 and LRP-6 Gene Mutations and Postmenopausal Type 2 Diabetes and Obesity.","authors":"Jun Li, Ya Li, Yunqiu Lu, Siyuan Li, Yecheng Zhu, Chuanbing Sun, Partab Rai, Xuehai Jia","doi":"10.1177/11795514241307180","DOIUrl":"10.1177/11795514241307180","url":null,"abstract":"<p><strong>Background: </strong>Single nucleotide polymorphisms (SNPs) in the low-density lipoprotein receptor-related protein 5 (LRP5) and the low-density lipoprotein receptor-related protein 5 (LRP6) genes have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and obesity (OB). This study aimed to evaluate the polymorphisms in LRP5 and LRP6 genes in postmenopausal patients with T2DM and OB.</p><p><strong>Methods: </strong>Participants were categorized into the Non-T2DM group (n = 53) and the T2DM group (n = 89) based on glycemic levels. Baseline data and biochemical indices were collected, Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry, and SNPs at the LRP5 and LRP6 loci were assessed by time-of-flight mass spectrometry.</p><p><strong>Results: </strong>1. There was a statistical difference in the distribution of genotypes (CC/CT) at locus rs4988331 (χ2 = 67.940, <i>P</i> = .000) and in the distribution of alleles (C/T) between the T2DM and non-T2DM groups (χ2 = 50.506, <i>P</i> = .000). Additionally, there were significant differences in the allele (G/A) at locus rs11054704, and both allele (G/T) and genotype (GG/GT) distributions at locus rs1181334 between the OB group and the normal weight group (<i>P</i> < .05). 2. OB was identified as a risk factor for T2DM in individuals with the wild-type at locus rs1181334, and the interaction between wild-type and mutant was significant (<i>P</i> < .05). 3. Multifactorial logistic regression analysis revealed that BMD (OR 3.755; 95% CI, 1.215-11.608) and triglyceride-glucose (TyG) index (OR 2.855; 95% CI, 1.361-5.986) were risk factors for T2DM in postmenopausal women, whereas alkaline phosphatase (ALP; OR 0.970; 95% CI, 0.945-0.995) and rs4988331 mutation (OR 0.018; 95% CI, 0.006-0.060) were protective factors.</p><p><strong>Conclusion: </strong>Mutations at the LRP5-rs4988331 locus, as well as the LRP6-rs11054704 and rs1181334 loci, may be associated with the development of T2DM and OB in postmenopausal women.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514241307180"},"PeriodicalIF":2.7,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11789129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetic Ketoacidosis in Pregnancy: A Systematic Review of the Reported Cases. 妊娠期糖尿病酮症酸中毒:报告病例的系统回顾。
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.1177/11795514241312849
Dimitra Stathi, Florence Ning Lee, Mili Dhar, Stergios Bobotis, Elisavet Arsenaki, Taruna Agrawal, Konstantinos Katsikas Triantafyllidis, Konstantinos S Kechagias

Background: Diabetic ketoacidosis (DKA) is a rare but serious complication that can develop during pregnancy, with up to 30% of patients presenting with euglycemia, making prompt recognition challenging. It is associated with increased perinatal mortality rates, although the exact risk of maternal mortality remains unclear. The purpose of this systematic review was to examine the available literature and provide an overview of reported cases of DKA during pregnancy.

Methods: PubMed, Web of Science and Scopus library databases were screened from inception until January 2024. Included studies provided data on classic or euglycemic DKA during pregnancy. All study designs were considered eligible for inclusion.

Results: We identified 66 eligible articles, which included 57 case reports and case series with individual patient data, and 9 studies without individual patient data. The mean age at diagnosis was 28.8 years, and the average gestational age at diagnosis was 29.5 weeks. The majority of women had type 1 diabetes mellitus (T1DM) (45.9%), followed by gestational diabetes (GDM) (40.5%). Most cases were classified as classic DKA (70.3%), with nearly one-third developing euglycemic DKA (29.7%). The most common trigger factors were infections (28%), followed by poor adherence to treatment (13.5%). The most frequent symptoms included nausea (32.4%), vomiting (32.4%), osmotic symptoms (21.6%), and abdominal pain (20.2%). All cases were treated with intravenous insulin and fluids. The vast majority (98.9%) of women eventually fully recovered, with only 1 reported death due to organ failure (1.3%). Intrauterine death or stillbirth occurred in one-third of cases (35.2%), including 1 instance of a twin pregnancy.

Conclusions: DKA is a condition that clinicians may encounter during pregnancy. Although rare, increased awareness and early recognition are crucial for optimal management and improved maternal and neonatal outcomes.

背景:糖尿病酮症酸中毒(DKA)是一种罕见但严重的并发症,可在妊娠期间发生,高达30%的患者表现为血糖正常,这使得及时识别具有挑战性。它与围产期死亡率增加有关,尽管产妇死亡的确切风险尚不清楚。本系统综述的目的是检查现有文献,并提供妊娠期间DKA报告病例的概述。方法:筛选PubMed、Web of Science和Scopus图书馆数据库,从建库至2024年1月。纳入的研究提供了妊娠期间经典DKA或正糖DKA的数据。所有的研究设计都被认为符合纳入条件。结果:我们确定了66篇符合条件的文章,其中包括57例病例报告和患者个体资料的病例系列,以及9项没有患者个体资料的研究。确诊时平均年龄28.8岁,确诊时平均胎龄29.5周。大多数女性患有1型糖尿病(T1DM)(45.9%),其次是妊娠糖尿病(GDM)(40.5%)。大多数病例为经典DKA(70.3%),近三分之一为正血糖DKA(29.7%)。最常见的触发因素是感染(28%),其次是治疗依从性差(13.5%)。最常见的症状包括恶心(32.4%)、呕吐(32.4%)、渗透症状(21.6%)和腹痛(20.2%)。所有病例均给予静脉注射胰岛素和液体治疗。绝大多数(98.9%)妇女最终完全康复,只有1例报告因器官衰竭死亡(1.3%)。三分之一的病例(35.2%)发生宫内死亡或死产,包括一例双胎妊娠。结论:DKA是临床医生在妊娠期间可能遇到的一种疾病。虽然罕见,但提高认识和早期识别对于优化管理和改善孕产妇和新生儿结局至关重要。
{"title":"Diabetic Ketoacidosis in Pregnancy: A Systematic Review of the Reported Cases.","authors":"Dimitra Stathi, Florence Ning Lee, Mili Dhar, Stergios Bobotis, Elisavet Arsenaki, Taruna Agrawal, Konstantinos Katsikas Triantafyllidis, Konstantinos S Kechagias","doi":"10.1177/11795514241312849","DOIUrl":"10.1177/11795514241312849","url":null,"abstract":"<p><strong>Background: </strong>Diabetic ketoacidosis (DKA) is a rare but serious complication that can develop during pregnancy, with up to 30% of patients presenting with euglycemia, making prompt recognition challenging. It is associated with increased perinatal mortality rates, although the exact risk of maternal mortality remains unclear. The purpose of this systematic review was to examine the available literature and provide an overview of reported cases of DKA during pregnancy.</p><p><strong>Methods: </strong>PubMed, Web of Science and Scopus library databases were screened from inception until January 2024. Included studies provided data on classic or euglycemic DKA during pregnancy. All study designs were considered eligible for inclusion.</p><p><strong>Results: </strong>We identified 66 eligible articles, which included 57 case reports and case series with individual patient data, and 9 studies without individual patient data. The mean age at diagnosis was 28.8 years, and the average gestational age at diagnosis was 29.5 weeks. The majority of women had type 1 diabetes mellitus (T1DM) (45.9%), followed by gestational diabetes (GDM) (40.5%). Most cases were classified as classic DKA (70.3%), with nearly one-third developing euglycemic DKA (29.7%). The most common trigger factors were infections (28%), followed by poor adherence to treatment (13.5%). The most frequent symptoms included nausea (32.4%), vomiting (32.4%), osmotic symptoms (21.6%), and abdominal pain (20.2%). All cases were treated with intravenous insulin and fluids. The vast majority (98.9%) of women eventually fully recovered, with only 1 reported death due to organ failure (1.3%). Intrauterine death or stillbirth occurred in one-third of cases (35.2%), including 1 instance of a twin pregnancy.</p><p><strong>Conclusions: </strong>DKA is a condition that clinicians may encounter during pregnancy. Although rare, increased awareness and early recognition are crucial for optimal management and improved maternal and neonatal outcomes.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"18 ","pages":"11795514241312849"},"PeriodicalIF":2.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733887/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Supplementation with Selenium and Myo-Inositol Versus Selenium Alone in Patients of Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis. 补充硒和肌醇与单独硒在自身免疫性甲状腺炎患者中的作用:系统回顾和荟萃分析
IF 3 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.1177/11795514241300998
Varisha Zuhair, Areeba Tufail Sheikh, Nimra Shafi, Areesha Babar, Areeb Khan, Arooba Sadiq, Muhammad Afnan Ashraf, Khuld Nihan, Muhammad Hamza, Burhan Khalid, Syeda Haya Fatima, Mirza Ammar Arshad, Eman Ali

Objective: The main objective was to assess the therapeutic efficacy of selenium alone versus a combination of myo-inositol and selenium (MI + Se) in treating patients with autoimmune thyroiditis (AIT). The study aims to determine which treatment option is more effective in restoring euthyroid state, as indicated by changes in thyroid-stimulating hormone (TSH), T3, T4, thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb).

Methods: Google Scholar and PubMed databases were searched for randomized controlled trials (RCTs) and observational studies that reported outcomes of combined treatment (MI + Se) in restoring a euthyroid state, specifically comparing it with selenium-only (Se-only) treatment. Changes in TSH, T3, T4, TPOAb, and TgAb levels from baseline were defined as indicators to compare the effect of combined versus selenium-only treatment in restoring euthyroid levels. The Cochrane risk of bias tool and Newcastle Ottawa Scale were used to assess the quality of the randomized control trials included in the study. Review Manager (version 5.4, Nordic Cochrane Centre, Copenhagen, Denmark) was used for statistical analysis.

Result: We pooled three studies, enrolling 151 participants in the MI + Se group and 137 participants in the Se group. Supplementation of Se with MI demonstrated a significant reduction in TSH levels compared to Se alone (SMD = -1.15, 95% CI: -1.60 to -0.69, P < .00001). MI + Se treatment also significantly reduced TgAb levels compared to Se (SMD = -0.51, 95% CI: -0.78 to -0.24, P = .0002). In contrast, TPOAB, T3 and T4 levels were non-significantly reduced from baseline in patients treated with MI + Se when compared to Se alone (SMD = -0.81, 95% CI: -0.44 to 0.09, P = .20), (SMD = 0.16, 95% CI: -0.09 to 0.42, P = .22), and (SMD = 0.30, 95% CI: -0.23 to 0.83, P = .26) respectively.

Conclusion: Supplementation of Se with MI showed a significant reduction in TSH and TgAb levels compared to selenium-only treatment, with a non-significant reduction in TPOAB, T3, and T4 levels. This entails the need for powered clinical trials and observational studies with longer follow-ups to critically assess the role of combined therapy in restoring euthyroid state in patients with AIT.

目的:主要目的是评估单独使用硒与肌醇加硒(MI + Se)联合治疗自身免疫性甲状腺炎(AIT)患者的疗效。该研究旨在通过促甲状腺激素(TSH)、T3、T4、甲状腺过氧化物酶抗体(TPOAb)和甲状腺球蛋白抗体(TgAb)的变化来确定哪种治疗方案更有效地恢复甲状腺正常状态。方法:检索谷歌Scholar和PubMed数据库,检索随机对照试验(rct)和观察性研究,这些研究报告了联合治疗(MI + Se)在恢复甲状腺正常状态方面的结果,特别是将其与仅硒(Se-only)治疗进行比较。TSH、T3、T4、TPOAb和TgAb水平从基线的变化被定义为比较联合治疗与单独硒治疗在恢复甲状腺功能水平方面的效果的指标。采用Cochrane偏倚风险工具和纽卡斯尔渥太华量表评估纳入本研究的随机对照试验的质量。使用Review Manager (version 5.4, Nordic Cochrane Centre, Copenhagen, Denmark)进行统计分析。结果:我们汇总了3项研究,MI + Se组入组151例,Se组入组137例。与单独使用硒相比,补充硒和心肌梗死可显著降低TSH水平(SMD = -1.15, 95% CI: -1.60至-0.69,P = 0.0002)。相比之下,与单独使用Se相比,MI + Se治疗的患者TPOAB、T3和T4水平较基线无显著降低(SMD = -0.81, 95% CI: -0.44至0.09,P = 0.20)、(SMD = 0.16, 95% CI: -0.09至0.42,P = 0.22)和(SMD = 0.30, 95% CI: -0.23至0.83,P = 0.26)。结论:与纯硒治疗相比,在心肌梗死中补充硒可显著降低TSH和TgAb水平,而TPOAB、T3和T4水平无显著降低。这就需要有动力的临床试验和长期随访的观察性研究,以严格评估联合治疗在恢复AIT患者甲状腺功能正常状态中的作用。
{"title":"Role of Supplementation with Selenium and Myo-Inositol Versus Selenium Alone in Patients of Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis.","authors":"Varisha Zuhair, Areeba Tufail Sheikh, Nimra Shafi, Areesha Babar, Areeb Khan, Arooba Sadiq, Muhammad Afnan Ashraf, Khuld Nihan, Muhammad Hamza, Burhan Khalid, Syeda Haya Fatima, Mirza Ammar Arshad, Eman Ali","doi":"10.1177/11795514241300998","DOIUrl":"10.1177/11795514241300998","url":null,"abstract":"<p><strong>Objective: </strong>The main objective was to assess the therapeutic efficacy of selenium alone versus a combination of myo-inositol and selenium (MI + Se) in treating patients with autoimmune thyroiditis (AIT). The study aims to determine which treatment option is more effective in restoring euthyroid state, as indicated by changes in thyroid-stimulating hormone (TSH), T3, T4, thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb).</p><p><strong>Methods: </strong>Google Scholar and PubMed databases were searched for randomized controlled trials (RCTs) and observational studies that reported outcomes of combined treatment (MI + Se) in restoring a euthyroid state, specifically comparing it with selenium-only (Se-only) treatment. Changes in TSH, T3, T4, TPOAb, and TgAb levels from baseline were defined as indicators to compare the effect of combined versus selenium-only treatment in restoring euthyroid levels. The Cochrane risk of bias tool and Newcastle Ottawa Scale were used to assess the quality of the randomized control trials included in the study. Review Manager (version 5.4, Nordic Cochrane Centre, Copenhagen, Denmark) was used for statistical analysis.</p><p><strong>Result: </strong>We pooled three studies, enrolling 151 participants in the MI + Se group and 137 participants in the Se group. Supplementation of Se with MI demonstrated a significant reduction in TSH levels compared to Se alone (SMD = -1.15, 95% CI: -1.60 to -0.69, <i>P</i> < .00001). MI + Se treatment also significantly reduced TgAb levels compared to Se (SMD = -0.51, 95% CI: -0.78 to -0.24, <i>P</i> = .0002). In contrast, TPOAB, T3 and T4 levels were non-significantly reduced from baseline in patients treated with MI + Se when compared to Se alone (SMD = -0.81, 95% CI: -0.44 to 0.09, <i>P</i> = .20), (SMD = 0.16, 95% CI: -0.09 to 0.42, <i>P</i> = .22), and (SMD = 0.30, 95% CI: -0.23 to 0.83, <i>P</i> = .26) respectively.</p><p><strong>Conclusion: </strong>Supplementation of Se with MI showed a significant reduction in TSH and TgAb levels compared to selenium-only treatment, with a non-significant reduction in TPOAB, T3, and T4 levels. This entails the need for powered clinical trials and observational studies with longer follow-ups to critically assess the role of combined therapy in restoring euthyroid state in patients with AIT.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"17 ","pages":"11795514241300998"},"PeriodicalIF":3.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Effects of HbA1c Reduction on Alleviating Chronic Nonspecific Low Back Pain in Prediabetic Non-obese Patients: A Non-Randomized Controlled Trial. 评估降低 HbA1c 对缓解糖尿病前期非肥胖患者慢性非特异性腰痛的影响:非随机对照试验。
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-17 eCollection Date: 2024-01-01 DOI: 10.1177/11795514241300995
Ghazwan Abdulla Hasan, Ahmed Dheyaa Al-Obaidi, Hashim Talib Hashim, Mustafa Najah Al-Obaidi, Yousif Ali Al-Saady, Assalah Othman, Sara S Khunda, Omar Saab, Hasan Al-Obaidi, Nooraldin Merza

Background: Pre-diabetes, characterized by elevated glycemic indices, poses a high risk of diabetes development, and is increasingly linked to non-specific low back pain. While mechanisms remain incompletely understood, metabolic, inflammatory, and neurological factors are implicated. Dietary interventions, including low-glycemic and anti-inflammatory diets, alongside weight management, may improve outcomes in this population.

Objectives: In this non-randomized controlled trial, we aim to evaluate the influence of decreasing HbA1c levels on reducing chronic non-specific low back pain in pre-diabetic, non-obese individuals, as well as emphasizing the importance of such a study in supporting the literature.

Methods: A non-randomized controlled single-blind clinical trial was conducted among 82 participants with chronic non-specific low back pain and pre-diabetes at an outpatient clinic in Baghdad from the 30th of January to the 22nd of September. The intervention methods aimed at reducing HbA1c levels to assess the reduction impact on alleviating chronic non-specific low back pain included dietary adjustments, sleep optimization, and correction of vitamins and minerals deficiencies. The follow-up process was conducted individually for each participant, with a monthly assessment over a period of six months.

Results: At 12 weeks a significant decrease in chronic non-specific low back pain severity was observed in patients with lower HbA1C levels yielding a P-value of .021. Similarly, at 24 weeks there was a decline in the number of patients who reported chronic non-specific low back pain, and the association to lower HbA1C levels was significant with a p-value of .005.

Conclusion: This study suggests the presence of a statistically significant association between reduction of HbA1C levels and ensuing improvement in chronic non-specific low back pain symptoms in non-obese prediabetic patients.

背景:以血糖指数升高为特征的糖尿病前期是糖尿病发展的高危因素,而且越来越多地与非特异性腰背痛联系在一起。虽然对其机理尚不完全清楚,但代谢、炎症和神经因素都与之有关。饮食干预措施,包括低血糖饮食和抗炎饮食,以及体重管理,可能会改善这类人群的治疗效果:在这项非随机对照试验中,我们旨在评估降低 HbA1c 水平对减轻糖尿病前期非肥胖人群慢性非特异性腰背痛的影响,同时强调此类研究在支持文献方面的重要性:1 月 30 日至 9 月 22 日,在巴格达的一家门诊诊所对 82 名患有慢性非特异性腰背痛和糖尿病前期的参与者进行了非随机对照单盲临床试验。干预方法旨在降低 HbA1c 水平,以评估降低 HbA1c 对缓解慢性非特异性腰背痛的影响,包括调整饮食、优化睡眠以及纠正维生素和矿物质缺乏症。随访过程针对每位参与者单独进行,在六个月内每月进行一次评估:结果:12 周后,HbA1C 水平较低的患者慢性非特异性腰背痛的严重程度明显减轻,P 值为 0.021。同样,在 24 周时,报告慢性非特异性腰背痛的患者人数也有所下降,且与 HbA1C 水平较低的关系显著,P 值为 0.005:本研究表明,非肥胖糖尿病前期患者 HbA1C 水平的降低与慢性非特异性腰背痛症状的改善之间存在统计学意义上的显著关联。
{"title":"Assessing the Effects of HbA1c Reduction on Alleviating Chronic Nonspecific Low Back Pain in Prediabetic Non-obese Patients: A Non-Randomized Controlled Trial.","authors":"Ghazwan Abdulla Hasan, Ahmed Dheyaa Al-Obaidi, Hashim Talib Hashim, Mustafa Najah Al-Obaidi, Yousif Ali Al-Saady, Assalah Othman, Sara S Khunda, Omar Saab, Hasan Al-Obaidi, Nooraldin Merza","doi":"10.1177/11795514241300995","DOIUrl":"10.1177/11795514241300995","url":null,"abstract":"<p><strong>Background: </strong>Pre-diabetes, characterized by elevated glycemic indices, poses a high risk of diabetes development, and is increasingly linked to non-specific low back pain. While mechanisms remain incompletely understood, metabolic, inflammatory, and neurological factors are implicated. Dietary interventions, including low-glycemic and anti-inflammatory diets, alongside weight management, may improve outcomes in this population.</p><p><strong>Objectives: </strong>In this non-randomized controlled trial, we aim to evaluate the influence of decreasing HbA1c levels on reducing chronic non-specific low back pain in pre-diabetic, non-obese individuals, as well as emphasizing the importance of such a study in supporting the literature.</p><p><strong>Methods: </strong>A non-randomized controlled single-blind clinical trial was conducted among 82 participants with chronic non-specific low back pain and pre-diabetes at an outpatient clinic in Baghdad from the 30th of January to the 22nd of September. The intervention methods aimed at reducing HbA1c levels to assess the reduction impact on alleviating chronic non-specific low back pain included dietary adjustments, sleep optimization, and correction of vitamins and minerals deficiencies. The follow-up process was conducted individually for each participant, with a monthly assessment over a period of six months.</p><p><strong>Results: </strong>At 12 weeks a significant decrease in chronic non-specific low back pain severity was observed in patients with lower HbA1C levels yielding a <i>P</i>-value of .021. Similarly, at 24 weeks there was a decline in the number of patients who reported chronic non-specific low back pain, and the association to lower HbA1C levels was significant with a <i>p</i>-value of .005.</p><p><strong>Conclusion: </strong>This study suggests the presence of a statistically significant association between reduction of HbA1C levels and ensuing improvement in chronic non-specific low back pain symptoms in non-obese prediabetic patients.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"17 ","pages":"11795514241300995"},"PeriodicalIF":2.7,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study. 甲状腺疾病患者病理结果的趋势:单中心回顾性研究
IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-09 eCollection Date: 2024-01-01 DOI: 10.1177/11795514241299709
Masooma Naseem, Sajjad Ali, Sara Qadir, Anshahrah Riaz, Abdullah Monawwer, Burhanuddin Tahir, Zehra Naseem, Zahid Mehmood

Background: Globally, a rising trend has been observed in the prevalence of thyroid disorders, with many demographic and geographic factors influencing its epidemiology. Nonetheless, some cases often go undetected due to the inconsistent and non-specific nature of the clinical symptoms. Therefore, we aimed to determine the trend and relationship between various pathological findings in thyroid disease patients and their demographic factors to aid clinicians in making a prompt diagnosis and treatment plan.

Methods: A descriptive correlational study was conducted from January 2020 to May 2022 at Jinnah Postgraduate Medical Center, Karachi. We collected data via random sampling from 258 patients suffering from thyroid disorders. We evaluated baseline patient characteristics, along with, thyroid scan and fine needle aspiration cytology (FNAC) reports, and local thyroid gland examination findings.

Results: Out of 258 participants, 192 (74.4%) were females, whereas 66 (25.6%) were males, giving a female: male ratio of 2.9: 1. On local examination, 167 (64.7%) were found to have a solitary nodule, 79 (30.6%) had multinodular goiter. Findings revealed that benign follicular lesions had the highest prevalence (35.3%). Moreover, among the cancerous growth, papillary carcinoma presented the highest cases (12.4%). Of 258 cases, 24 patients had non-surgical interventions, while most (234) had surgical interventions. Total thyroidectomy was the most common procedure opted for by 45.3% (n = 117) of the participants, followed by lobectomy 70 (27.1%), near total thyroidectomy 43 (13.2%), modified radical neck dissection 5 (1.9%).

Conclusion: Our study showed that nearly all thyroid-related pathologies were more prevalent amongst females than males, with the majority having an acute to sub-acute clinical presentation. Multinodular goiter was a prominent finding indicating a greater need for screening tools and access to healthcare facilities, especially in rural areas, to allow future studies to compare provinces accurately.

背景:在全球范围内,甲状腺疾病的发病率呈上升趋势,其流行病学受到许多人口和地理因素的影响。然而,由于临床症状的不一致性和非特异性,一些病例往往未被发现。因此,我们旨在确定甲状腺疾病患者的各种病理结果与人口因素之间的趋势和关系,以帮助临床医生及时做出诊断和制定治疗方案:2020年1月至2022年5月,我们在卡拉奇真纳研究生医学中心开展了一项描述性相关研究。我们通过随机抽样的方式收集了 258 名甲状腺疾病患者的数据。我们评估了患者的基线特征、甲状腺扫描和细针穿刺细胞学(FNAC)报告以及甲状腺局部检查结果:在 258 名参与者中,192 人(74.4%)为女性,66 人(25.6%)为男性,男女比例为 2.9:1。局部检查发现,167 人(64.7%)有单发结节,79 人(30.6%)有多结节性甲状腺肿。研究结果显示,良性滤泡性病变的发病率最高(35.3%)。此外,在癌变中,乳头状癌的发病率最高(12.4%)。在258个病例中,24名患者接受了非手术治疗,而大多数患者(234人)接受了手术治疗。甲状腺全切除术是最常见的手术,有45.3%的参与者(n = 117)选择了这种手术,其次是甲状腺叶切除术70例(27.1%)、近甲状腺全切除术43例(13.2%)、改良根治性颈部切除术5例(1.9%):我们的研究表明,几乎所有与甲状腺有关的病症在女性中的发病率都高于男性,而且大多数病症的临床表现为急性或亚急性。多结节性甲状腺肿是一个突出的发现,这表明需要更多的筛查工具和医疗设施,尤其是在农村地区,以便未来的研究能够准确比较各省的情况。
{"title":"Trends of Pathological Findings in Patients with Thyroid Diseases: A Single-center, Retrospective Study.","authors":"Masooma Naseem, Sajjad Ali, Sara Qadir, Anshahrah Riaz, Abdullah Monawwer, Burhanuddin Tahir, Zehra Naseem, Zahid Mehmood","doi":"10.1177/11795514241299709","DOIUrl":"https://doi.org/10.1177/11795514241299709","url":null,"abstract":"<p><strong>Background: </strong>Globally, a rising trend has been observed in the prevalence of thyroid disorders, with many demographic and geographic factors influencing its epidemiology. Nonetheless, some cases often go undetected due to the inconsistent and non-specific nature of the clinical symptoms. Therefore, we aimed to determine the trend and relationship between various pathological findings in thyroid disease patients and their demographic factors to aid clinicians in making a prompt diagnosis and treatment plan.</p><p><strong>Methods: </strong>A descriptive correlational study was conducted from January 2020 to May 2022 at Jinnah Postgraduate Medical Center, Karachi. We collected data via random sampling from 258 patients suffering from thyroid disorders. We evaluated baseline patient characteristics, along with, thyroid scan and fine needle aspiration cytology (FNAC) reports, and local thyroid gland examination findings.</p><p><strong>Results: </strong>Out of 258 participants, 192 (74.4%) were females, whereas 66 (25.6%) were males, giving a female: male ratio of 2.9: 1. On local examination, 167 (64.7%) were found to have a solitary nodule, 79 (30.6%) had multinodular goiter. Findings revealed that benign follicular lesions had the highest prevalence (35.3%). Moreover, among the cancerous growth, papillary carcinoma presented the highest cases (12.4%). Of 258 cases, 24 patients had non-surgical interventions, while most (234) had surgical interventions. Total thyroidectomy was the most common procedure opted for by 45.3% (n = 117) of the participants, followed by lobectomy 70 (27.1%), near total thyroidectomy 43 (13.2%), modified radical neck dissection 5 (1.9%).</p><p><strong>Conclusion: </strong>Our study showed that nearly all thyroid-related pathologies were more prevalent amongst females than males, with the majority having an acute to sub-acute clinical presentation. Multinodular goiter was a prominent finding indicating a greater need for screening tools and access to healthcare facilities, especially in rural areas, to allow future studies to compare provinces accurately.</p>","PeriodicalId":44715,"journal":{"name":"Clinical Medicine Insights-Endocrinology and Diabetes","volume":"17 ","pages":"11795514241299709"},"PeriodicalIF":2.7,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Medicine Insights-Endocrinology and Diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1